Deutsche Bank AG Increases Stake in Agilent Technologies, Inc. $A

Deutsche Bank AG increased its position in shares of Agilent Technologies, Inc. (NYSE:A) by 17.1% during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 7,008,634 shares of the medical research company’s stock after buying an additional 1,024,516 shares during the period. Deutsche Bank AG’s holdings in Agilent Technologies were worth $930,957,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently made changes to their positions in the company. Fiduciary Trust Co increased its position in Agilent Technologies by 1.6% during the 3rd quarter. Fiduciary Trust Co now owns 4,931 shares of the medical research company’s stock valued at $633,000 after purchasing an additional 77 shares during the period. Sapient Capital LLC lifted its position in shares of Agilent Technologies by 4.2% in the 1st quarter. Sapient Capital LLC now owns 2,105 shares of the medical research company’s stock worth $240,000 after purchasing an additional 85 shares during the period. Plan A Wealth LLC lifted its position in shares of Agilent Technologies by 3.2% in the 4th quarter. Plan A Wealth LLC now owns 2,959 shares of the medical research company’s stock worth $403,000 after purchasing an additional 92 shares during the period. IHT Wealth Management LLC boosted its stake in shares of Agilent Technologies by 4.9% during the fourth quarter. IHT Wealth Management LLC now owns 2,041 shares of the medical research company’s stock valued at $278,000 after purchasing an additional 96 shares in the last quarter. Finally, KPP Advisory Services LLC boosted its stake in shares of Agilent Technologies by 2.4% during the second quarter. KPP Advisory Services LLC now owns 4,382 shares of the medical research company’s stock valued at $582,000 after purchasing an additional 103 shares in the last quarter.

Analysts Set New Price Targets

Several equities analysts recently issued reports on the stock. HSBC cut their price objective on shares of Agilent Technologies from $180.00 to $165.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. Piper Sandler assumed coverage on Agilent Technologies in a research report on Thursday, June 11th. They set a “neutral” rating and a $150.00 target price on the stock. Barclays boosted their price target on Agilent Technologies from $145.00 to $150.00 and gave the stock an “overweight” rating in a research report on Wednesday, June 24th. Robert W. Baird upped their price objective on Agilent Technologies from $155.00 to $156.00 and gave the stock an “outperform” rating in a research note on Tuesday, May 26th. Finally, Royal Bank Of Canada began coverage on Agilent Technologies in a research report on Wednesday, May 27th. They set an “outperform” rating and a $153.00 price objective on the stock. Two research analysts have rated the stock with a Strong Buy rating, thirteen have assigned a Buy rating and four have given a Hold rating to the company’s stock. According to data from MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $160.24.

Agilent Technologies Trading Up 0.1%

NYSE:A opened at $148.65 on Tuesday. Agilent Technologies, Inc. has a 52 week low of $108.35 and a 52 week high of $160.27. The firm has a 50 day moving average of $135.70 and a 200 day moving average of $125.58. The company has a quick ratio of 1.62, a current ratio of 2.10 and a debt-to-equity ratio of 0.43. The stock has a market capitalization of $41.98 billion, a price-to-earnings ratio of 29.85, a PEG ratio of 2.63 and a beta of 1.25.

Agilent Technologies (NYSE:A) last announced its earnings results on Wednesday, May 27th. The medical research company reported $1.49 earnings per share for the quarter, beating the consensus estimate of $1.41 by $0.08. Agilent Technologies had a net margin of 19.55% and a return on equity of 24.33%. The company had revenue of $1.83 billion during the quarter, compared to the consensus estimate of $1.80 billion. During the same period last year, the firm earned $1.31 earnings per share. Agilent Technologies’s revenue was up 10.0% compared to the same quarter last year. Agilent Technologies has set its FY 2026 guidance at 6.000-6.100 EPS and its Q3 2026 guidance at 1.480-1.500 EPS. As a group, sell-side analysts anticipate that Agilent Technologies, Inc. will post 6.03 earnings per share for the current fiscal year.

Agilent Technologies Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, July 22nd. Stockholders of record on Tuesday, June 30th were given a $0.255 dividend. The ex-dividend date of this dividend was Tuesday, June 30th. This represents a $1.02 dividend on an annualized basis and a dividend yield of 0.7%. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.48%.

Agilent Technologies Company Profile

Agilent Technologies is a global provider of scientific instrumentation, consumables, software and services for laboratories across the life sciences, diagnostics and applied chemical markets. The company’s product portfolio includes analytical instruments such as liquid and gas chromatographs, mass spectrometers, spectroscopy systems, and laboratory automation solutions, together with reagents, supplies and informatics tools that support measurement, testing and data analysis workflows. Agilent also offers instrument maintenance, qualification and laboratory services designed to help customers improve productivity and comply with regulatory requirements.

Founded as a corporate spin-off from Hewlett‑Packard in 1999, Agilent has evolved through a combination of strategic restructuring and acquisitions to concentrate on life sciences, diagnostics and applied laboratories.